FDA Clears PixCell’s CBC Analyzer for Direct Capillary Sampling
The U.S. FDA has granted 510(k) clearance for PixCell’s direct capillary sampling with the HemoScreen five-part differential CBC analyzer.
Read MorePosted by Andy Lundin | Sep 25, 2023 | Hematology & Serology |
The U.S. FDA has granted 510(k) clearance for PixCell’s direct capillary sampling with the HemoScreen five-part differential CBC analyzer.
Read MorePosted by Andy Lundin | Sep 22, 2023 | Covid 19 |
QuidelOrtho, a provider of innovative in vitro diagnostic technologies designed for point-of-care...
Read MorePosted by Andy Lundin | Sep 21, 2023 | Point-of-Care |
An interdisciplinary team received a grant to launch a center for engineering, testing, and commercializing point-of-care diagnostic devices.
Read MorePosted by Chris Wolski | Sep 20, 2023 | Immunoassay Reagents & test Kits |
The digital PCR assay kit co-quantifies respiratory pathogens SARS-CoV-2, influenza A, influenza B, and RSV.
Read MorePosted by Andy Lundin | Sep 18, 2023 | Womens Health |
Desired fetal diagnostic tech from the NIH includes wearable devices, in vitro diagnostic tests, imaging devices, and sensor technologies.
Read More